Imani S - Search Results

1

Epigenetic identification of ADCY4 as a biomarker for breast cancer: an integrated analysis of adenylate cyclases.

Fan Y, Mu J, Huang M, Imani S, Wang Y, Lin S, Fan J, Wen Q. Fan Y, et al. Among authors: imani s. Epigenomics. 2019 Nov;11(14):1561-1579. doi: 10.2217/epi-2019-0207. Epub 2019 Oct 4. Epigenomics. 2019. PMID: 31584294

2

Evaluation of PIK3CA mutations as a biomarker in Chinese breast carcinomas from Western China.

Cheng J, Fu S, Wei C, Tania M, Khan MA, Imani S, Zhou B, Chen H, Xiao X, Wu J, Fu J. Cheng J, et al. Among authors: imani s. Cancer Biomark. 2017;19(1):85-92. doi: 10.3233/CBM-160380. Cancer Biomark. 2017. PMID: 28269754

3

The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.

Imani S, Zhang X, Hosseinifard H, Fu S, Fu J. Imani S, et al. Oncotarget. 2017 Apr 4;8(14):23177-23187. doi: 10.18632/oncotarget.15520. Oncotarget. 2017. PMID: 28423566 Free PMC article. Review.

4

The role of vascular mimicry as a biomarker in malignant melanoma: a systematic review and meta-analysis.

Zhang Z, Imani S, Shasaltaneh MD, Hosseinifard H, Zou L, Fan Y, Wen Q. Zhang Z, et al. Among authors: imani s. BMC Cancer. 2019 Nov 21;19(1):1134. doi: 10.1186/s12885-019-6350-5. BMC Cancer. 2019. PMID: 31752759 Free PMC article.

5

Associations of serum low-density lipoprotein and systolic blood pressure levels with type 2 diabetic patients with and without peripheral neuropathy: systemic review, meta-analysis and meta-regression analysis of observational studies.

Naqvi SSZH, Imani S, Hosseinifard H, Wen QL, Shahzad MN, Ijaz I, Deng Y, Guo M, Xu Y. Naqvi SSZH, et al. Among authors: imani s. BMC Endocr Disord. 2019 Nov 25;19(1):125. doi: 10.1186/s12902-019-0453-5. BMC Endocr Disord. 2019. PMID: 31767009 Free PMC article.

6

Comparison of different images in gross target volume delineating on VX2 nasopharyngeal transplantation tumor models.

Xiang ZQ, Imani S, Hu Y, Ding RL, Pang HW, Chen Y, Fu SZ, Xie F, He WF, Wen QL. Xiang ZQ, et al. Among authors: imani s. J Cancer. 2020 Jan 1;11(5):1104-1114. doi: 10.7150/jca.36076. eCollection 2020. J Cancer. 2020. PMID: 31956357 Free PMC article.

7

Bevacizumab combined with apatinib enhances antitumor and anti-angiogenesis effects in a lung cancer model in vitro and in vivo.

Wang M, Zeng Q, Li Y, Imani S, Xie D, Li Y, Han Y, Fan J. Wang M, et al. Among authors: imani s. J Drug Target. 2020 Nov;28(9):961-969. doi: 10.1080/1061186X.2020.1764963. Epub 2020 May 18. J Drug Target. 2020. PMID: 32374627

8

Targeting IFN/STAT1 Pathway as a Promising Strategy to Overcome Radioresistance.

Liu S, Imani S, Deng Y, Pathak JL, Wen Q, Chen Y, Wu J. Liu S, et al. Among authors: imani s. Onco Targets Ther. 2020 Jun 24;13:6037-6050. doi: 10.2147/OTT.S256708. eCollection 2020. Onco Targets Ther. 2020. PMID: 32606809 Free PMC article. Review.

9

Anlotinib Suppresses Colorectal Cancer Proliferation and Angiogenesis via Inhibition of AKT/ERK Signaling Cascade.

Yang Q, Ni L, Imani S, Xiang Z, Hai R, Ding R, Fu S, Wu JB, Wen Q. Yang Q, et al. Among authors: imani s. Cancer Manag Res. 2020 Jun 24;12:4937-4948. doi: 10.2147/CMAR.S252181. eCollection 2020. Cancer Manag Res. 2020. PMID: 32606981 Free PMC article.

10

Genome‑wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis.

Zou L, Imani S, Maghsoudloo M, Shasaltaneh MD, Gao L, Zhou J, Wen Q, Liu S, Zhang L, Chen G. Zou L, et al. Among authors: imani s. Oncol Rep. 2020 Sep;44(3):1075-1093. doi: 10.3892/or.2020.7650. Epub 2020 Jun 18. Oncol Rep. 2020. PMID: 32705227 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters